{"nct_id":"NCT04878211","title":"A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2021-06-10","start_date_type":"ACTUAL","primary_completion_date":"2023-04-14","primary_completion_date_type":"ACTUAL","completion_date":"2023-04-14","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}